Cost-effectiveness analysis of PET-guided BrECADD with chemotherapy in advanced-stage, classical Hodgkin lymphoma
Authors
- Bo Cai (ORCID: https://orcid.org/0000-0002-9208-4445)
- Hui Li (ORCID: https://orcid.org/0000-0001-9198-3951)
- Yuhang Liu (ORCID: https://orcid.org/0000-0001-9151-5146)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Guihao Zeng
Institutions
- Guangdong Pharmaceutical University (CN)
- Peking University (CN)
- Peking University International Hospital (CN)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2026-06-16
- DOI
- https://doi.org/10.1186/s12962-026-00757-6
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00